TotalMarketCap

Revolution Medicines

RVMDNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$38.469 B

$177.86 -10.94%

Close of 6 Nov 2026

As of 6 Nov 2026, Revolution Medicines (RVMD) has a market capitalization of $38.5B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$1.13B

Loss-making

Shares outstanding

216,292,323

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Revolution Medicines lists more than one class of stock. Company figures above cover all classes combined.

RVMDW

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #3ModernaMRNA$96.5B
  2. #4Argenx SeARGX$55.8B
  3. #5Revolution MedicinesRVMD$38.5B
  4. #6BiogenBIIB$36.1B
  5. #7BioNTech SEBNTX$21.6B

What if Revolution Medicines were worth as much as…

Open the what-if tool →

Gold $28.2T

$130,549.59

Per share 734× higher

Bitcoin $1.53T

$7,063.81

Per share 39.7× higher

Apple $5.02T

$23,189.83

Per share 130× higher

Or at a round number

$50.0B$100.0B$200.0B$500.0B

Where these numbers come from

Share counts and financials for Revolution Medicines are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.